LAZARD ASSET MANAGEMENT LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 48 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$37,809,000
+15.6%
37,786,000
+16.3%
0.04%
+8.1%
Q3 2021$32,717,000
-10.0%
32,500,000
-11.0%
0.04%
-9.8%
Q2 2021$36,347,000
-10.6%
36,500,000
-6.4%
0.04%
-16.3%
Q1 2021$40,659,000
+137.7%
39,000,000
+116.3%
0.05%
+122.7%
Q4 2020$17,102,000
-10.1%
18,031,000
-13.8%
0.02%
-18.5%
Q3 2020$19,030,000
+11.4%
20,928,000
+6.0%
0.03%
+12.5%
Q4 2019$17,090,000
+20.3%
19,745,000
+16.1%
0.02%
+4.3%
Q3 2019$14,211,000
+64.1%
17,000,000
+70.0%
0.02%
+64.3%
Q2 2019$8,658,00010,000,0000.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$38,988,0001.44%
Penn Mutual Asset Management, LLC 1,204,000$1,174,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,148,0000.96%
PALISADE CAPITAL MANAGEMENT, LP 10,006,000$9,832,0000.23%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,431,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 20,353,000$19,882,0000.21%
Wellesley Asset Management 2,304$2,245,0000.15%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,719,0000.12%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,942,0000.11%
Cutler Capital Management, LLC 300,000$291,0000.10%
View complete list of LIGAND PHARMACEUTICALS INC shareholders